ellacor® System
Improvement in the appearance of moderate to severe wrinkles in the mid to lower face (Fitzpatrick skin types I-IV)
Key Facts
About Cytrellis Biosystems
Cytrellis Biosystems is a private, commercial-stage medical device company focused on the dermatology and aesthetics market. Its core innovation is the ellacor® system, an FDA-cleared device that employs a novel Micro-Coring® technology to physically remove small columns of skin, addressing moderate to severe wrinkles and skin laxity. The company has launched an updated version, ellacor® 2.0, and is led by a team with extensive experience in medical device development and commercialization. Cytrellis operates in the large and growing non-surgical aesthetic treatment market, positioning itself as a differentiated technology between energy-based devices and invasive surgery.
View full company profile